BA vs DMAC
The Boeing Company (BA) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
DMAC does not have a complete income-statement cache yet.
BA currently screens at market cap $177.86B and trailing P/E 89.2. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the BA and DMAC stock pages for the full models.
Not investment advice.